Research Repository

Competition and Drug Pricing in the PBS: An Economic Interpretation

Sheehan, Peter and Sweeny, Kim (2002) Competition and Drug Pricing in the PBS: An Economic Interpretation. Working Paper. Victoria University, Melbourne, Australia.

[img] Text (Full Paper)
15916.pdf

Download (58kB)

Abstract

The paper will describe and attempt to assess some of the evidence in relation to six hypotheses. It is very preliminary. In its subsequent development it will attempt to pull together evidence from international sources and other Australian studies, from our case studies and from our analyses of various data sources, to assess these hypotheses. The six hypotheses are as follows. 1. Increasing Role of Benefit Paid Pharmaceuticals. 2. Highly Regulated Prices, with Administered Competition. 3. Extensive Non-Price Competition between Suppliers. 4. Low and Short-Lived Returns to Innovation. 5. Relatively High Price, Low Volume Approach to Generics. 6. Duopoly Situation for Many Post-Patent Drugs.

Item Type: Monograph (Working Paper)
Additional Information:

Pharmaceutical Industry Project Equity, Sustainability and Industry Development Working Paper

Uncontrolled Keywords: Pharmaceuticals Benefit Scheme, PBS, Australian health system
Subjects: FOR Classification > 1402 Applied Economics
Faculty/School/Research Centre/Department > Centre for Strategic Economic Studies (CSES)
Depositing User: VUIR
Date Deposited: 07 Dec 2010 00:51
Last Modified: 23 May 2013 16:46
URI: http://vuir.vu.edu.au/id/eprint/15916
DOI: No. 12
ePrint Statistics: View download statistics for this item

Repository staff only

View Item View Item

Search Google Scholar